Ventricular tachycardia medical therapy: Difference between revisions
Avirupguha (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Ventricular tachycardia}} | {{Ventricular tachycardia}} | ||
{{CMG}};'''Associate Editor-In-Chief:''' {{CZ}}, [[User:Avirupguha|Avirup Guha, M.B.B.S.]][mailto:avirup.guha@gmail.com] | {{CMG}};'''Associate Editor-In-Chief:''' {{CZ}}, [[User:Avirupguha|Avirup Guha, M.B.B.S.]][mailto:avirup.guha@gmail.com] | ||
==Antiarrhythmic drug therapy== | |||
Drugs such as [[amiodarone]], [[epinephrine]] and [[vasopressin]] may be used in addition to [[defibrillation]] to terminate VT while the underlying cause of the VT can be determined. Possible causes or contributing factors to VT can be remembered as the six H's and five T's: Hypovolemia, Hypoxia, Hydrogen ion (acidosis), Hypo- or Hyperglycemia, Hypothermia; and Toxins, Tamponade (cardiac), Tension pneumothorax, Thrombosis, Trauma. | Drugs such as [[amiodarone]], [[epinephrine]] and [[vasopressin]] may be used in addition to [[defibrillation]] to terminate VT while the underlying cause of the VT can be determined. Possible causes or contributing factors to VT can be remembered as the six H's and five T's: Hypovolemia, Hypoxia, Hydrogen ion (acidosis), Hypo- or Hyperglycemia, Hypothermia; and Toxins, Tamponade (cardiac), Tension pneumothorax, Thrombosis, Trauma. | ||
| Line 11: | Line 12: | ||
The implantation of an [[ICD]] is more effective than drug therapy for prevention of sudden cardiac death due to [[VT]] and [[VF]], but may be constrained by cost issues, and well as patient co-morbidities and patient preference. | The implantation of an [[ICD]] is more effective than drug therapy for prevention of sudden cardiac death due to [[VT]] and [[VF]], but may be constrained by cost issues, and well as patient co-morbidities and patient preference. | ||
== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Electrophysiology]] | |||
[[Category : | [[Category:Cardiology]] | ||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} | ||
Revision as of 14:39, 30 October 2012
|
Ventricular tachycardia Microchapters |
|
Differentiating Ventricular Tachycardia from other Disorders |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Ventricular tachycardia medical therapy On the Web |
|
to Hospitals Treating Ventricular tachycardia medical therapy |
|
Risk calculators and risk factors for Ventricular tachycardia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Avirup Guha, M.B.B.S.[3]
Antiarrhythmic drug therapy
Drugs such as amiodarone, epinephrine and vasopressin may be used in addition to defibrillation to terminate VT while the underlying cause of the VT can be determined. Possible causes or contributing factors to VT can be remembered as the six H's and five T's: Hypovolemia, Hypoxia, Hydrogen ion (acidosis), Hypo- or Hyperglycemia, Hypothermia; and Toxins, Tamponade (cardiac), Tension pneumothorax, Thrombosis, Trauma.
Long term anti-arrhythmic therapy may be indicated to prevent recurrence of VT. Beta-blockers and a number of class III anti-arrhythmics are commonly used.
For some of the rare congenital syndromes of VT, other drugs, and sometimes even catheter ablation therapy may be useful.
The implantation of an ICD is more effective than drug therapy for prevention of sudden cardiac death due to VT and VF, but may be constrained by cost issues, and well as patient co-morbidities and patient preference.